Publications by authors named "J E Torra-Bou"
Incisional negative pressure wound therapy for the prevention of surgical site complications in Paediatric patients with non-idiopathic scoliosis: A randomized clinical trial.
Int Wound J
September 2024
Article Synopsis
- Surgical wound complications, particularly surgical site infections and wound dehiscences, significantly impact the health of pediatric patients, especially those treated for non-idiopathic scoliosis.
- This study aims to assess the cost-effectiveness of using incisional negative pressure wound therapy compared to traditional dressing methods in preventing these complications in children after surgery.
- Results show a notable reduction in complications, with 7.7% in the intervention group versus 38.5% in the control group, indicating that negative pressure wound therapy could be a beneficial preventive measure in this context.
Article Synopsis
- * A scoping review analyzed 28 studies and identified four major themes: community care settings, types and management of wounds, prevention strategies, and local wound care management.
- * The research highlights a lack of existing studies on wound care in community settings, emphasizing the complexity of DRSI management and the importance of personalized prevention strategies for effective treatment.
Introduction: Purpura fulminans (PF) is a serious complication of sepsis resulting from a set of alterations characterised by the development of ecchymotic haemorrhagic lesions and skin necrosis.
Aim: To analyse the efficacy and safety of the topical application of HOFA compound, in the cutaneous microcirculation of PF lesions in paediatric patients affected by sepsis.
Material And Methods: A prospective quasi-experimental pre-test/post-test single-group conducted in a Paediatric Intensive Care Unit of a third level hospital was performed.
Background: Chronic wounds are susceptible to colonization with gram-positive and gram-negative bacteria that may be resistant to antimicrobial dressings and systemic antibiotics. In January 2004, the US Food and Drugs Administration approved use of medicinal larvae for use in humans and animals for resistant organisms. Despite use in adults, there is a paucity of evidence evaluating its efficacy and safety in the pediatric population.
View Article and Find Full Text PDFPurpura fulminans is a severe and rapidly progressive septic process characterised by the development of haemorrhagic and ecchymotic lesions and skin necrosis. It can appear on any part of the body but predominantly affects the limbs. Purpura fulminans is a rare but possible complication in paediatric patients, especially neonates.
View Article and Find Full Text PDF